The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana merger earlier this fall.

The Cigna Group reported a $739 million third quarter net income despite a $1 billion loss on its investment in ...

Cigna surpassed quarterly profit estimates on Thursday, driven by strong demand for its specialty drugs and new clients for ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Cigna surpassed Wall Street estimates for third-quarter profit on Thursday, driven by high demand for biosimilars of a ...

CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset ...

The Cigna Group on Thursday reported a nearly $740 million profit for the third quarter of 2024, despite an after-tax loss of ...

On Thursday, Cigna Corporation (NYSE:CI) reported third-quarter sales of $63.7 billion, up 30% year-over-year, beating the ...

Verdence Capital Advisors LLC trimmed its position in The Cigna Group (NYSE:CI – Free Report) by 36.0% in the third quarter, ...

Equities researchers at Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of The Cigna Group in a ...

The Cigna Group (NYSE: CI) has reported robust financial results for the third quarter of 2024, showcasing a significant ...

Cigna exceeded quarterly profit projections, fueled by high demand for specialty drugs and new clients in its pharmacy benefit management sector. The company enjoyed a 2% premarket share increase and ...